Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

2.35USD
22 Mar 2019
Change (% chg)

$0.05 (+2.17%)
Prev Close
$2.30
Open
$2.29
Day's High
$2.35
Day's Low
$2.20
Volume
54,790
Avg. Vol
31,430
52-wk High
$4.56
52-wk Low
$1.25

Chart for

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for .

Overall

Beta: 2.04
Market Cap(Mil.): $149.74
Shares Outstanding(Mil.): 63.72
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 99.54 58.10
EPS (TTM): -0.19 -- --
ROI: -498.82 7.80 12.12
ROE: -568.79 7.82 13.24

Earnings vs. Estimates